Healthcare Services

Enteric Softgel Capsules Market Developments and Growth Opportunities Across 2026–2030

April 1, 2026April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Enteric Softgel Capsules Market From 2026 To 2030?

The enteric softgel capsules market size has experienced consistent expansion in recent years. This market is projected to grow from $2.44 billion in 2025 to $2.55 billion in 2026, at a compound annual growth rate (CAGR) of 4.7%. The historical growth can be linked to the demand for digestive health supplements, the preference for oral drug delivery, advancements in softgel formulations, growing consumer health awareness, and innovations in pharmaceutical dosage.

The enteric softgel capsules market size is projected to experience consistent expansion over the upcoming years, reaching $3.05 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.6%. This anticipated growth during the forecast period stems from factors such as vegan capsule demand, personalized nutrition growth, controlled-release formulation development, pharmaceutical outsourcing expansion, and a focus on preventive healthcare. Key developments anticipated in this period encompass a rising demand for targeted drug delivery, growth in nutraceutical consumption, increased use of acid-resistant formulations, expansion of plant-based capsule adoption, and an emphasis on improved bioavailability.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20775&type=smp

What Drivers Are Influencing The Enteric Softgel Capsules Market?

The growing occurrence of nutrition disorders is anticipated to propel the expansion of the enteric softgel capsules market moving forward. Nutritional disorders are conditions resulting from an imbalance in nutrient intake, whether from a deficit or an excess of essential vitamins, minerals, proteins, fats, and carbohydrates. The rising incidence of these disorders is fueled by factors such as poor dietary habits, inactive lifestyles, limited access to nutritious food, increased consumption of processed foods, and socio-economic obstacles that impede proper nutrition. Enteric softgel capsules aid in managing nutritional disorders by delivering vital nutrients in a way that safeguards them from stomach acid, ensuring their targeted release in the intestines where absorption is most efficient. This process improves nutrient bioavailability and supports overall digestive health and nutritional balance. For instance, in 2024, a report from the Food and Agriculture Organization, a Canada-based specialized agency, indicated that global undernourishment remained at 9.1 percent in 2023. Furthermore, food insecurity affected 11.5 percent of the population in 2023. Consequently, the increasing incidence of nutrition disorders is driving the growth of the enteric softgel capsules market.

Which Segments Are Included In The Analysis Of The Enteric Softgel Capsules Market?

The enteric softgel capsules market covered in this report is segmented –

1) By Type: Gelatin Capsules, Non-Gelatin Softgel Capsules

2) By Distribution Channel: Supermarkets And Hypermarkets, Pharmacy And Drug Stores, Online Stores

3) By Application: Antacid And Antiflatulent Preparations, Anti-Inflammatory Drugs, Antibiotic And Antibacterial Drugs, Cough And Cold Preparations, Health Supplements, Vitamin And Dietary Supplements, Other Therapeutic Applications

4) By End User: Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies, Food Industry

Subsegments:

1) By Gelatin Capsules: Bovine Gelatin Softgel Capsules, Porcine Gelatin Softgel Capsules, Fish Gelatin Softgel Capsules

2) By Non-Gelatin Softgel Capsules: Plant-Based Softgel Capsules, Vegan Softgel Capsules, Polymer-Based Softgel Capsules

What Trends Are Advancing Progress In The Enteric Softgel Capsules Market?

Leading firms within the enteric softgel capsules market are concentrating on innovating, specifically by advancing plant-based softgel excipient systems designed for acid-resistant intestinal release. These innovations aim to boost stability, increase bioavailability, and facilitate clean-label, vegan products. Such plant-derived softgel excipient systems utilize polymers not sourced from animals, like hydroxypropyl pea starch, to create shells that withstand stomach acid, ensuring active components are released in the intestine. This offers a distinct advantage over conventional gelatin softgels, which can dissolve prematurely in the stomach, potentially compromising acid-sensitive ingredients. An example of this trend is seen in April 2024, when Roquette, a plant-based ingredient provider based in France, introduced LYCAGEL, an excipient derived from hydroxypropyl pea starch for use in plant-based softgels. This offering empowers manufacturers to produce vegan, clean-label softgels featuring acid-resistant properties, safeguarding delicate nutraceuticals such as omega-3s and probiotics, while also enhancing bioavailability and removing the requirement for gelatin.

Which Key Industry Participants Are Active In The Enteric Softgel Capsules Market?

Major companies operating in the enteric softgel capsules market are BASF SE, United Laboratories International Inc., Herbalife Nutrition Ltd., Catalent Pharma Solutions Inc., Sirio Pharma Co. Ltd., NOW Health Group Inc., Patheon, GELITA AG, Colorcon Inc., Aenova Group GmbH, ProCaps Laboratories Inc., CAPTEK Softgel International Inc., Renown Pharmaceuticals Private Limited, Viva Pharmaceutical Inc., Biofield Pharma Private Limited, CapsCanada Corporation, Natural Capsules Limited, Fuji Capsules Co. Ltd., Conch Lifescience Co. Ltd., Lonza Group Ltd., EuroCaps Ltd., Strides Pharma Science Limited, Emcure Pharmaceuticals Limited, Soft Gel Technologies Inc.

Read the full enteric softgel capsules market report here:

https://www.thebusinessresearchcompany.com/report/enteric-softgel-capsules-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Enteric Softgel Capsules Market?

North America was the largest region in the enteric softgel capsules market in 2025. The regions covered in the enteric softgel capsules market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Enteric Softgel Capsules Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20775&type=smp

Browse Through More Reports Similar to the Global Enteric Softgel Capsules Market 2026, By The Business Research Company

Gastrointestinal Pathogen Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/gastrointestinal-pathogen-testing-global-market-report

Infectious Disease Diagnostics Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

Food Pathogen Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/food-pathogen-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795